ALFA Finder
17:21 IST
NSE
Board Meeting Date
Balaxi Pharmaceuticals Board Meeting Date
Balaxi Pharmaceuticals will meet on 12 November 2026 to approve unaudited half-year results. The trading window stays closed until 14 November 2026.
Balaxi Pharmaceuticals Ltd
- Share price
- ₹23.35
- Market cap
- ₹128.9 Cr
- Revenue (annual)
- ₹270.2 Cr
- Net profit (annual)
- ₹1.42 Cr
- P/E (TTM)
- 53.2×Sector 43.8×
- Promoter holding
- 65.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 5Other Announcement 3Board Meeting Date 3Earnings Call 2Business Update 2Annual General Meeting 2Results Correction 1Price Movement Clarification 1Management Change 1Board Meeting Outcome 1
Time
3 announcements with these filters
13:15 IST
NSE
Board Meeting Date
Balaxi Pharmaceuticals Board Meeting Date
Balaxi Pharmaceuticals will hold a board meeting on August 5, 2026, to consider and approve its unaudited standalone and consolidated financial results for the June 2026 quarter.
19:30 IST
NSE
Board Meeting Date
Balaxi Pharmaceuticals Board Meeting Date
Balaxi Pharmaceuticals scheduled a board meeting on May 28, 2026, to approve audited FY2026 financial results. Trading window remains closed until May 30, 2026.